4.7 Article

Dry-reagent microfluidic biosensor for simple detection of NT-proBNP via Ag nanoparticles

Journal

ANALYTICA CHIMICA ACTA
Volume 1191, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.aca.2021.339375

Keywords

Electrochemical biosensor; Silver nanoparticle; Microfluidic; Blood analysis; Differential pulse voltammetry

Ask authors/readers for more resources

The microfluidic biosensor has key characteristics of desirable home-tests, including low limits of detection, small sample volume, simple detection strategies, and long-term stable reagents. It can accurately assess the severity and progression of diseases.
The diagnosis of many diseases requires monitoring of biomarker levels over a period of time instead of assessing their concentration only once. For example, in case of heart failure determination, the levels of N-terminal prohormone brain natriuretic peptide (NT-proBNP) in blood vary so strongly amongst individuals, that the current procedure of one-time measurement in combination with clinical examination does not allow for accurate assessment of disease severity and progression. Our microfluidic biosensor addresses key characteristics of desirable home-tests which include low limits of detection, small sample volume (less than 10 mL), simple detection strategies, and ready-to-go all-dried long-term stable reagents. Here, electrochemically superior silver nanoparticles (AgNP) were dried directly within the microfluidic channel in a matrix of trehalose sugar doped with Na2SO3 as oxygen scavenger. This successfully prevented AgNP oxidation and enabled dry and ready-to-use storage for at least 18 weeks. Based on this, laser-cut flow chips were developed containing all bioassay reagents needed in a ready-togo dry format. An oxidation-reduction stripping voltammetry strategy was used for highly sensitive quantification of the AgNPs as electrochemical label. This microfluidic biosensor demonstrated limits of detection for NT-proBNP of 0.57 ng mL-1 with a mean error of 6% (n > 3) in undiluted human serum, which is below the clinically relevant cut-off of 1 ng mL-1. This practical approach has the potential to substitute commonly used lateral-flow assays for various biomarkers, as it offers low patient sample volumes hence supporting simple finger-prick strategies well-known also for other electrochemical biosensors, and independence from the notorious variability in fleece fabrication. (c) 2021 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available